We Are Here To Make A Difference
Leading a paradigm shift in genetic medicine
We Are Here To Make A Difference
Leading a paradigm shift in genetic medicine
We Are Here To Make A Difference
Leading a paradigm shift in genetic medicine
Emedgene was founded on the vision that genetic medicine will inevitably be the medical standard of care, and on the strong belief that what has already become a known fact in science, should be used to serve the community of patients.
We share the commitment of our users, geneticists and clinicians alike, to provide better care to patients in need every day.
Emedgene Values
Patient – First Medicine
We believe that every single patient deserves a chance, and are humbled by the possibility of changing their lives for the best. We don’t stop when the data stops, and like our platform, we are devoted to continuously working on unsolved cases.
Multidisciplinarity Makes Progress
We believe anything can be solved by putting brilliant minds from different disciplines in one room and have them work together on solving a difficult problem. Our teams are comprised of exceptional scientists, technologists, bioinformaticians and clinicians, because an unsolved problem is just a problem in need of new perspectives.
An executive with years of operational experience in product, sales and business development in software companies. Previously Investment Manager with Gemini Israel Ventures, Einat advised portfolio companies on strategy and business development in diverse industries including Enterprise Software and Healthcare IT.
Leading geneticist with vast experience in research & commercial applications of Next
Generation Sequencing data for clinical use. Previously owner of Genome interpretation company, and Head of Clinical Genomics at Gene by Gene. Shay leads the emedgene research center and has published >30 research papers.
Generation Sequencing data for clinical use. Previously owner of Genome interpretation company, and Head of Clinical Genomics at Gene by Gene. Shay leads the emedgene research center and has published >30 research papers.
Expert in big data and large-scale distributed systems, Niv is a highly experienced R&D manager. Previously Director of Engineering at Taykey, Niv helped build an R&D organization from the ground up, and lead dozens of developers to a successful implementation of complex big data systems.
An executive with years of operational experience in product, sales and business development in software companies. Previously Investment Manager with Gemini Israel Ventures, Einat advised portfolio companies on strategy and business development in diverse industries including Enterprise Software and Healthcare IT.
Leading geneticist with vast experience in research & commercial applications of Next
Generation Sequencing data for clinical use. Previously owner of Genome interpretation company, and Head of Clinical Genomics at Gene by Gene. Shay leads the emedgene research center and has published >30 research papers.
Generation Sequencing data for clinical use. Previously owner of Genome interpretation company, and Head of Clinical Genomics at Gene by Gene. Shay leads the emedgene research center and has published >30 research papers.
Expert in big data and large-scale distributed systems, Niv is a highly experienced R&D manager. Previously Director of Engineering at Taykey, Niv helped build an R&D organization from the ground up, and lead dozens of developers to a successful implementation of complex big data systems.